Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Jack Leslie
Newcastle Authors
Title
Year
Full text
Anna Smith
Dr Julia Whitehall
Carla Bradshaw
Dr Fiona Robertson
Dr Alasdair Blain
et al.
Age-associated mitochondrial DNA mutations cause metabolic remodeling that contributes to accelerated intestinal tumorigenesis
2020
Dr Julie Worrell
Dr Jack Leslie
Dr Graham Smith
Marco Zaki
Hannah Paish
et al.
cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis
2020
Dr Jack Leslie
Dr Marina Garcia Macia
Dr Saimir Luli
Dr Julie Worrell
William Reilly
et al.
c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis
2020
Dr Jack Leslie
Benjamin Millar
Alicia Del Carpio Pons
Rachel Burgoyne
Joseph Frost
et al.
FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis
2020
Dr Jack Leslie
Dr Emma Scott
Professor Quentin Anstee
Professor Fiona Oakley
Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma
2020
Dr Jack Leslie
Professor Fiona Oakley
Loss of ELK1 has differential effects on age-dependent organ fibrosis
2020
Hannah Paish
Lee Reed
Helen Brown
Mark Bryan
Dr Olivier Govaere
et al.
A bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices
2019
Hannah Paish
Lee Reed
Abi Watson
Dr Jack Leslie
Professor Fiona Oakley
et al.
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
2019
Dr Dumitru Sirbu
Dr Saimir Luli
Dr Jack Leslie
Professor Fiona Oakley
Professor Andrew Benniston
et al.
Enhanced in vivo Optical Imaging of the Inflammatory Response to Acute Liver Injury in C57BL/6 Mice using a Highly Bright Near-Infrared BODIPY Dye
2019
Dr Caroline Wilson
Dr Jack Leslie
Professor Derek Mann
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
2019
1
2